Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]

Lung Cancer. 2024 Nov:197:108000. doi: 10.1016/j.lungcan.2024.108000. Epub 2024 Nov 2.
No abstract available

Publication types

  • Published Erratum